Reports on Prostate Cancer Findings from National Institutes of Health Provide New Insights (Risk of Alzheimer’s Disease Among Senior Medicare…
Reports on Prostate Cancer Findings from
By a
Our news journalists obtained a quote from the research from the
According to the news editors, the research concluded: "These data suggest that ADT treatment has no hazard for AD and no meaningful hazard for dementia among men age 67 years or older who are enrolled in Medicare."
For more information on this research see: Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer.
The news correspondents report that additional information may be obtained from C.J. McDonald, US Natl Inst Hlth,
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC
The Miller Law Firm Recovers over $18,000,000 for Six Oakland Homeowners Associations with Construction Defects
Day care’s insurer questions liability in boy’s death after family requests $1 million settlement
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News